Depomed Inc. appointed Santosh Vetticaden senior vice president and chief medical and scientific officer of the company.
Vetticaden was most recently the interim CEO of Insys Therapeutics Inc.
Discover more about S&P Global’s offerings
Depomed adds chief medical/scientific officer
Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in
A Cloud Migration Plan for Corporations featuring Snowflake®
Investor Activism Campaigns Hit Record High in 2022
Essential IR Insights Newsletter - February 2023
Depomed Inc. appointed Santosh Vetticaden senior vice president and chief medical and scientific officer of the company.
Vetticaden was most recently the interim CEO of Insys Therapeutics Inc.